{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:39:29Z","timestamp":1791362369695,"version":"4.3.1"},"reference-count":125,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"am","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI152183"],"award-info":[{"award-number":["R01AI152183"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HG010863"],"award-info":[{"award-number":["R01HG010863"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R13AR078623"],"award-info":[{"award-number":["R13AR078623"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AI154659"],"award-info":[{"award-number":["U01AI154659"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UAI109565"],"award-info":[{"award-number":["UAI109565"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jaip.2022.12.002","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T02:39:37Z","timestamp":1671503977000},"page":"356-368.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Drug Allergy Practice Parameter Updates to Incorporate Into Your Clinical Practice"],"prefix":"10.1016","volume":"11","author":[{"given":"Aleena","family":"Banerji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Solensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2022.12.002_bib1","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update","volume":"150","author":"Khan","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib2","doi-asserted-by":"crossref","first-page":"e872","DOI":"10.1093\/cid\/ciaa1762","article-title":"Association of \u03b2-lactam allergy documentation and prophylactic antibiotic use in surgery: a national cross-sectional study of hospitalized patients","volume":"72","author":"Bertram","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2022.12.002_bib3","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamainternmed.2020.2227","article-title":"Association between penicillin allergy documentation and antibiotic use","volume":"180","author":"Blumenthal","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaip.2022.12.002_bib4","article-title":"Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study","volume":"361","author":"Blumenthal","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2022.12.002_bib5","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s11606-019-04991-y","article-title":"Recorded penicillin allergy and risk of mortality: a population-based matched cohort study","volume":"34","author":"Blumenthal","year":"2019","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jaip.2022.12.002_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159406","article-title":"The impact of reporting a prior penicillin allergy on the treatment of methicillin-sensitive Staphylococcus aureus bacteremia","volume":"11","author":"Blumenthal","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2022.12.002_bib7","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2013.09.021","article-title":"Health care use and serious infection prevalence associated with penicillin \u201callergy\u201d in hospitalized patients: a cohort study","volume":"133","author":"Macy","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib8","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.1993.03510200062033","article-title":"Clinical experience with penicillin skin testing in a large inner-city STD clinic","volume":"270","author":"Gadde","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2022.12.002_bib9","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/archinte.1992.00400170105020","article-title":"Results of the National Institute of Allergy and Infectious Diseases Collaborative Clinical Trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults","volume":"152","author":"Sogn","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2022.12.002_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1081-1206(10)60882-4","article-title":"Penicillin skin testing in patients with a history of beta-lactam allergy","volume":"98","author":"del Real","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0025-6196(11)60893-8","article-title":"Preoperative evaluation of patients with history of allergy to penicillin: comparison of 2 models of practice","volume":"83","author":"Frigas","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaip.2022.12.002_bib12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaip.2017.02.012","article-title":"The effect of penicillin allergy testing on future health care utilization: a matched cohort study","volume":"5","author":"Macy","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1081-1206(10)61016-2","article-title":"Clinical outcomes of penicillin skin testing","volume":"95","author":"Nadarajah","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib14","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1081-1206(10)61100-3","article-title":"Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy","volume":"97","author":"Park","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jhm.2036","article-title":"The impact of penicillin skin testing on clinical practice and antimicrobial stewardship","volume":"8","author":"Rimawi","year":"2013","journal-title":"J\u00a0Hosp Med"},{"key":"10.1016\/j.jaip.2022.12.002_bib16","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jaip.2017.08.006","article-title":"The cost of penicillin allergy evaluation","volume":"6","author":"Blumenthal","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib17","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/cid\/ciaa194","article-title":"Penicillin allergy testing is cost-saving: an economic evaluation study","volume":"72","author":"Sousa-Pinto","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2022.12.002_bib18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jaci.2020.04.058","article-title":"Accuracy of penicillin allergy diagnostic tests: a systematic review and meta-analysis","volume":"147","author":"Sousa-Pinto","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jaci.2010.08.025","article-title":"The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge","volume":"127","author":"Caubet","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jaip.2017.02.023","article-title":"Oral challenge without skin testing safely excludes clinically significant delayed-onset penicillin hypersensitivity","volume":"5","author":"Confino-Cohen","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib21","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.jaip.2018.01.030","article-title":"Efficacy and safety of 5-day challenge for the evaluation of nonsevere amoxicillin allergy in children","volume":"6","author":"Labrosse","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib22","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2016.0033","article-title":"Assessing the diagnostic properties of a graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in children","volume":"170","author":"Mill","year":"2016","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jaip.2022.12.002_bib23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaip.2014.11.001","article-title":"Amoxicillin allergy in children: five-day drug provocation test in the diagnosis of nonimmediate reactions","volume":"3","author":"Mori","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib24","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.jaip.2019.05.037","article-title":"Comparing direct challenge to penicillin skin testing for the outpatient evaluation of penicillin allergy: a randomized controlled trial","volume":"7","author":"Mustafa","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib25","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaip.2018.05.008","article-title":"Safety and outcomes of oral graded challenges to amoxicillin without prior skin testing","volume":"7","author":"Iammatteo","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib26","first-page":"159","article-title":"Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock","volume":"38","author":"Idsoe","year":"1968","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jaip.2022.12.002_bib27","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jaci.2014.08.018","article-title":"Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations","volume":"134","author":"Jerschow","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jaip.2018.06.023","article-title":"Provocation tests in nonimmediate hypersensitivity reactions to \u03b2-lactam antibiotics in children: are extended challenges needed?","volume":"7","author":"Garc\u00eda Rodr\u00edguez","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib29","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.jaip.2019.04.021","article-title":"The limited value of prolonged drug challenges in nonimmediate amoxicillin (clavulanic acid) hypersensitivity","volume":"7","author":"Van Gasse","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib30","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jaip.2019.06.001","article-title":"Cephalosporin allergy: current understanding and future challenges","volume":"7","author":"Khan","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib31","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaci.2014.07.062","article-title":"Adverse reactions associated with oral and parenteral use of cephalosporins: a retrospective population-based analysis","volume":"135","author":"Macy","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib32","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/all.12881","article-title":"Drug allergies documented in electronic health records of a large healthcare system","volume":"71","author":"Zhou","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.12.002_bib33","first-page":"515","article-title":"Allergy to cefazolin: study of in\u00a0vivo cross reactivity with other betalactams","volume":"68","author":"Igea","year":"1992","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaip.2022.12.002_bib34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1398-9995.1995.tb01160.x","article-title":"Hypersensitivity to cefuroxime with good tolerance to other betalactams","volume":"50","author":"Marcos Bravo","year":"1995","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.12.002_bib35","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1592\/phco.24.6.668.34753","article-title":"Cefazolin tolerance does not predict ceftriaxone hypersensitivity: unique side chains precipitate anaphylaxis","volume":"24","author":"Poston","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jaip.2022.12.002_bib36","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0091-6749(99)70100-4","article-title":"A\u00a0case of IgE-mediated hypersensitivity to ceftriaxone","volume":"104","author":"Romano","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib37","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0091-6749(98)70368-9","article-title":"Selective type-1 hypersensitivity to cefuroxime","volume":"101","author":"Romano","year":"1998","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib38","first-page":"171","article-title":"Nonirritating concentration for skin testing with cephalosporins","volume":"20","author":"Testi","year":"2010","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib39","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jaci.2015.03.012","article-title":"IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of alternative cephalosporins","volume":"136","author":"Romano","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib40","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0091-6749(03)01783-4","article-title":"Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics","volume":"112","author":"Empedrad","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib41","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1016\/j.jaip.2019.05.038","article-title":"Cross-reactivity to cephalosporins and carbapenems in penicillin-allergic patients: two systematic reviews and meta-analyses","volume":"7","author":"Picard","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib42","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1398-9995.1994.tb00809.x","article-title":"Allergic reactions to betalactams: studies in a group of patients allergic to penicillin and evaluation of cross-reactivity with cephalosporin","volume":"49","author":"Audicana","year":"1994","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.12.002_bib43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0091-6749(89)90122-X","article-title":"Cross-reactivity between penicillins and cephalosporins: clinical and immunologic studies","volume":"83","author":"Blanca","year":"1989","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib44","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1016\/j.jaci.2004.12.740","article-title":"Utility of penicillin major and minor determinants for identification of allergic reactions to cephalosporins","volume":"115","author":"Greenberger","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib45","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1034\/j.1398-9995.2002.23700.x","article-title":"Oral antibiotic adverse reactions after penicillin skin testing: multi-year follow-up","volume":"57","author":"Macy","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.12.002_bib46","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1365-2222.2001.00992.x","article-title":"Lack of allergic cross-reactivity to cephalosporins among patients allergic to penicillins","volume":"31","author":"Novalbos","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2022.12.002_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0022-3476(98)70499-8","article-title":"Diagnosis of penicillin, amoxicillin, and cephalosporin allergy: reliability of examination assessed by skin testing and oral challenge","volume":"132","author":"Pichichero","year":"1998","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2022.12.002_bib48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7326\/0003-4819-141-1-200407060-00010","article-title":"Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins","volume":"141","author":"Romano","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2022.12.002_bib49","doi-asserted-by":"crossref","first-page":"204","DOI":"10.7326\/0003-4819-107-2-204","article-title":"Immediate hypersensitivity reactions to beta-lactam antibiotics","volume":"107","author":"Saxon","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2022.12.002_bib50","first-page":"262","article-title":"Administration of cephalosporin antibiotics to patients\u00a0with a history of penicillin allergy","volume":"91","author":"Shepherd","year":"1993","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib51","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0091-6749(82)90105-1","article-title":"Penicillin allergy: clinical experience with a battery of skin-test reagents","volume":"69","author":"Solley","year":"1982","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib52","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000333553","article-title":"Clinical outcome in the use of cephalosporins in pediatric patients with a history of penicillin allergy","volume":"158","author":"Ahmed","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib53","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000314367","article-title":"Increased adverse drug reactions to cephalosporins in penicillin allergy patients with positive penicillin skin test","volume":"153","author":"Park","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib54","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0091-6749(96)70101-X","article-title":"Cross-reactivity between a penicillin and a cephalosporin with the same side chain","volume":"98","author":"Miranda","year":"1996","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib55","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1398-9995.1996.tb00146.x","article-title":"Clinical cross-reactivity between amoxicillin and cephadroxil in patients allergic to amoxicillin and with good tolerance of penicillin","volume":"51","author":"Sastre","year":"1996","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.12.002_bib56","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/cid\/ciu587","article-title":"A\u00a0systematic review: can one prescribe carbapenems to patients with IgE-mediated allergy to penicillins or cephalosporins?","volume":"59","author":"Kula","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2022.12.002_bib57","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1086\/317507","article-title":"Incidence of imipenem hypersensitivity reactions in febrile neutropenic bone marrow transplant patients with a history of penicillin allergy","volume":"31","author":"McConnell","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2022.12.002_bib58","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1086\/382880","article-title":"Incidence of carbapenem-associated allergic-type reactions among patients with versus patients without a reported penicillin allergy","volume":"38","author":"Prescott","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2022.12.002_bib59","doi-asserted-by":"crossref","first-page":"266","DOI":"10.7326\/0003-4819-146-4-200702200-00005","article-title":"Tolerability of meropenem in patients with IgE-mediated hypersensitivity to penicillins","volume":"146","author":"Romano","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2022.12.002_bib60","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1081-1206(10)62226-0","article-title":"Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions","volume":"87","author":"Sanchez-Borges","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib61","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0091-6749(88)91001-9","article-title":"Imipenem cross-reactivity with penicillin in humans","volume":"82","author":"Saxon","year":"1988","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib62","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/jac\/dkh454","article-title":"Is it safe to use carbapenems in patients with a history of allergy to penicillin?","volume":"54","author":"Sodhi","year":"2004","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jaip.2022.12.002_bib63","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1398-9995.1991.tb00570.x","article-title":"Tolerance to aztreonam in patients allergic to beta-lactam antibiotics","volume":"46","author":"Vega","year":"1991","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.12.002_bib64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0002-9343(85)90198-6","article-title":"Investigation into the immunologic cross-reactivity of aztreonam with other beta-lactam antibiotics","volume":"78","author":"Saxon","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2022.12.002_bib65","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/infdis\/149.1.16","article-title":"Lack of cross-reactivity between aztreonam, a monobactam antibiotic, and penicillin in penicillin-allergic subjects","volume":"149","author":"Saxon","year":"1984","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jaip.2022.12.002_bib66","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0091-6749(91)90215-A","article-title":"Sensitization to aztreonam and cross-reactivity with other beta-lactam antibiotics in high-risk patients with cystic fibrosis","volume":"87","author":"Moss","year":"1991","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib67","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1128\/AAC.25.1.93","article-title":"Immunology of the monobactam aztreonam","volume":"25","author":"Adkinson","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaip.2022.12.002_bib68","doi-asserted-by":"crossref","first-page":"S613","DOI":"10.1093\/clinids\/7.Supplement_4.S613","article-title":"Cross-allergenicity and immunogenicity of aztreonam","volume":"7","author":"Adkinson","year":"1985","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jaip.2022.12.002_bib69","first-page":"S3","article-title":"Immunogenicity and cross-allergenicity of aztreonam","volume":"88","author":"Adkinson","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2022.12.002_bib70","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1398-9995.1998.tb03944.x","article-title":"Aztreonam and ceftazidime: evidence of in\u00a0vivo cross allergenicity","volume":"53","author":"Perez Pimiento","year":"1998","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.12.002_bib71","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1590\/S1413-86702002000600002","article-title":"A\u00a0randomized, pilot trial comparing full versus escalating dose regimens for the desensitization of AIDS patients allergic to sulfonamides","volume":"6","author":"Straatmann","year":"2002","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jaip.2022.12.002_bib72","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1086\/323353","article-title":"Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ","volume":"184","author":"Leoung","year":"2001","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jaip.2022.12.002_bib73","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0753-3322(00)88640-0","article-title":"The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study. C.I.S.A.I. Group","volume":"54","author":"Bonfanti","year":"2000","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jaip.2022.12.002_bib74","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0149-2918(04)90170-1","article-title":"Safety profile of oral and intravenous moxifloxacin: cumulative data from clinical trials and postmarketing studies","volume":"26","author":"Ball","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaip.2022.12.002_bib75","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ijantimicag.2004.02.014","article-title":"A\u00a0new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context","volume":"23","author":"Ball","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jaip.2022.12.002_bib76","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2165\/00002018-199921050-00005","article-title":"Comparative tolerability of the newer fluoroquinolone antibacterials","volume":"21","author":"Ball","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2022.12.002_bib77","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/j.1365-2222.2009.03338.x","article-title":"Diagnostic testing in suspected fluoroquinolone hypersensitivity","volume":"39","author":"Seitz","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2022.12.002_bib78","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/cea.12099","article-title":"Hypersensitivity reactions to fluoroquinolones: analysis of the factors involved","volume":"43","author":"Blanca-Lopez","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2022.12.002_bib79","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2165\/00002018-200629110-00008","article-title":"Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use","volume":"29","author":"Sachs","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2022.12.002_bib80","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2165\/00002018-200730080-00007","article-title":"Incidence of allergic reactions associated with antibacterial use in a large, managed care organisation","volume":"30","author":"Johannes","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2022.12.002_bib81","article-title":"Clinical characterization and diagnostic approaches for patients reporting hypersensitivity reactions to quinolones","volume":"8","author":"Do\u00f1a","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib82","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4168\/aair.2017.9.4.347","article-title":"Usefulness of in\u00a0vivo and in\u00a0vitro diagnostic tests in the diagnosis of hypersensitivity reactions to quinolones and in the evaluation of cross-reactivity: a comprehensive study including the latest quinolone gemifloxacin","volume":"9","author":"Demir","year":"2017","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2022.12.002_bib83","first-page":"607","article-title":"Allergy to quinolones: low cross-reactivity to levofloxacin","volume":"20","author":"Lobera","year":"2010","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib84","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0895-4356(98)00041-9","article-title":"Skin reactions to antibacterial agents in general practice","volume":"51","author":"van der Linden","year":"1998","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jaip.2022.12.002_bib85","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/jac\/37.suppl_C.143","article-title":"Paediatric safety of azithromycin: worldwide experience","volume":"37","author":"Treadway","year":"1996","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jaip.2022.12.002_bib86","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.aller.2010.06.008","article-title":"Suspicion of macrolide allergy after treatment of infectious diseases including Helicobacter pylori: results of allergological testing","volume":"39","author":"Seitz","year":"2011","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2022.12.002_bib87","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.anai.2010.03.010","article-title":"Sensitivity and specificity of skin tests in the diagnosis of clarithromycin allergy","volume":"104","author":"Mori","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib88","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/00015550510042859","article-title":"Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period","volume":"85","author":"Lammintausta","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2022.12.002_bib89","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jaip.2015.09.015","article-title":"Testing for clarithromycin hypersensitivity: a diagnostic challenge in childhood","volume":"4","author":"Cavkaytar","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib90","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1398-9995.2004.00638.x","article-title":"The accuracy of the diagnosis of suspected macrolide antibiotic hypersensitivity: results of a single-blinded trial","volume":"59","author":"Benahmed","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.12.002_bib91","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jaip.2016.10.021","article-title":"Current knowledge and management of hypersensitivity to aspirin and NSAIDs","volume":"5","author":"Laidlaw","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib92","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2500\/aap.2013.34.3670","article-title":"The clinical dilemma of \u201csilent desensitization\u201d in aspirin-exacerbated respiratory disease","volume":"34","author":"White","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2022.12.002_bib93","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1164\/rccm.201906-1215OC","article-title":"Omalizumab for aspirin hypersensitivity and leukotriene overproduction in aspirin-exacerbated respiratory disease. A randomized controlled trial","volume":"201","author":"Hayashi","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2022.12.002_bib94","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.jaip.2018.12.014","article-title":"Sinus surgery is associated with a decrease in aspirin-induced reaction severity in patients with aspirin exacerbated respiratory disease","volume":"7","author":"Jerschow","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib95","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/alr.22789","article-title":"Perioperative management and perceived risks of sinus surgery in patients with aspirin-exacerbated respiratory disease","volume":"11","author":"Wangberg","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2022.12.002_bib96","article-title":"Clinical control of CSU with antihistamines allows for tolerance of NSAID-exacerbated cutaneous disease","volume":"8","author":"S\u00e1nchez","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib97","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.anai.2016.08.020","article-title":"Tolerance to nonsteroidal anti-inflammatory drugs and alcohol after omalizumab treatment in a patient with chronic urticaria","volume":"117","author":"Walters","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib98","doi-asserted-by":"crossref","first-page":"226","DOI":"10.23822\/EurAnnACI.1764-1489.36","article-title":"Restoration of aspirin tolerance following omalizumab treatment in a patient with chronic spontaneous urticaria","volume":"50","author":"Asero","year":"2018","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib99","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jaip.2021.11.006","article-title":"Safety, outcomes, and recommendations for two-step outpatient nonsteroidal anti-inflammatory drug challenges","volume":"10","author":"Li","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib100","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/cod.13351","article-title":"Clinical features, culprit drugs, and allergology workup in 41 cases of fixed drug eruption","volume":"81","author":"Fadhel","year":"2019","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.12.002_bib101","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/all.13068","article-title":"Clinical approach on challenge and desensitization procedures with aspirin in patients with ischemic heart disease and nonsteroidal anti-inflammatory drug hypersensitivity","volume":"72","author":"Cortellini","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.12.002_bib102","article-title":"A\u00a0multicenter retrospective study on hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) in children: a report from the European Network on Drug Allergy (ENDA) group","volume":"8","author":"Mori","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib103","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(18)32218-9","article-title":"Antibiotic allergy","volume":"393","author":"Blumenthal","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.12.002_bib104","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.jaip.2020.07.005","article-title":"Delabeling delayed drug hypersensitivity: how far can you safely go?","volume":"8","author":"Lehloenya","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaci.2018.10.030","article-title":"Controversies in drug allergy: testing for delayed reactions","volume":"143","author":"Phillips","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib106","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jaip.2017.01.025","article-title":"Severe delayed cutaneous and systemic reactions to drugs: a global perspective on the science and art of current practice","volume":"5","author":"Peter","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib107","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2022.12.002_bib108","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/cpt.2343","article-title":"Immunopharmacogenomics: mechanisms of HLA-associated drug reactions","volume":"110","author":"Deshpande","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2022.12.002_bib109","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1073\/pnas.1207934109","article-title":"Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire","volume":"109","author":"Ostrov","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2022.12.002_bib110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jaci.2020.05.050","article-title":"Pharmacogenomic biomarkers in allergy and immunology practice","volume":"146","author":"Khan","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib111","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaci.2019.01.045","article-title":"HLA-A\u221732:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms","volume":"144","author":"Konvinse","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib112","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B\u22175701 screening for hypersensitivity to abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.12.002_bib114","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fmed.2020.00156","article-title":"Intradermal tests with drugs: an approach to standardization","volume":"7","author":"Barbaud","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2022.12.002_bib115","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jaip.2018.11.041","article-title":"Treatment can be continued for mild cutaneous reactions associated with efavirenz","volume":"7","author":"Isaacs","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib116","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1016\/j.jaip.2021.04.008","article-title":"Treating through drug-associated exanthems in drug allergy management: current evidence and clinical aspects","volume":"9","author":"Trubiano","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib117","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jaip.2020.08.012","article-title":"Early high-dose intravenous corticosteroids rapidly arrest Stevens-Johnson syndrome and drug reaction with eosinophilia and systemic symptoms recurrence on drug re-exposure","volume":"9","author":"Lehloenya","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib118","article-title":"Controversies in allergy: chemotherapy reactions, desensitize, or delabel?","volume":"8","author":"Hong","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib119","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.anai.2015.07.017","article-title":"Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy","volume":"115","author":"Wang","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib120","doi-asserted-by":"crossref","first-page":"e630","DOI":"10.3747\/co.21.1966","article-title":"Management of hypersensitivity to platinum- and taxane-based chemotherapy: cepo review and clinical recommendations","volume":"21","author":"Boulanger","year":"2014","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jaip.2022.12.002_bib121","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jaip.2017.08.025","article-title":"Utility of risk stratification for paclitaxel hypersensitivity reactions","volume":"6","author":"Otani","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib122","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.anai.2016.05.013","article-title":"Hypersensitivity and immunologic reactions to biologics: opportunities for the allergist","volume":"117","author":"Khan","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.12.002_bib123","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jaip.2017.01.025","article-title":"Severe delayed cutaneous and systemic reactions to drugs: a global perspective on the science and art of current practice","volume":"5","author":"Peter","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib124","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1016\/j.jaip.2021.04.008","article-title":"Treating through drug-associated exanthems in drug allergy management: current evidence and clinical aspects","volume":"9","author":"Trubiano","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib125","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jaip.2020.08.012","article-title":"Early high-dose intravenous corticosteroids rapidly arrest Stevens-Johnson syndrome and drug reaction with eosinophilia and systemic symptoms recurrence on drug re-exposure","volume":"9","author":"Lehloenya","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.002_bib126","article-title":"Controversies in allergy: chemotherapy reactions, desensitize, or delabel?","volume":"8","author":"Hong","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822013046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822013046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:35:57Z","timestamp":1761975357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219822013046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":125,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2213219822013046"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2022.12.002","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug Allergy Practice Parameter Updates to Incorporate Into Your Clinical Practice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2022.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}